Pfizer’s request to OK shots for kids a relief for parents

Parents tired of worrying about classroom outbreaks and sick of telling their elementary school-age children no to sleepovers and family gatherings felt a wave of relief Thursday when Pfizer asked the U.S. government to authorize its COVID-19 vaccine for youngsters ages 5 to 11.

If regulators give the go-ahead, reduced-dose kids’ shots could begin within a matter of weeks.